Drug Shortage Report for PRIVA-ATORVASTATIN
Report ID | 124227 |
Drug Identification Number | 02482916 |
Brand name | PRIVA-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | PHARMAPAR INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-09-14 |
Estimated end date | 2021-02-04 |
Actual end date | 2021-03-27 |
Shortage status | Resolved |
Updated date | 2021-08-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2021-08-03 | French | Compare |
v12 | 2021-08-03 | English | Compare |
v11 | 2021-02-05 | French | Compare |
v10 | 2021-02-05 | English | Compare |
v9 | 2021-01-22 | French | Compare |
v8 | 2021-01-22 | English | Compare |
v7 | 2020-12-15 | French | Compare |
v6 | 2020-12-15 | English | Compare |
v5 | 2020-11-13 | French | Compare |
v4 | 2020-11-13 | English | Compare |
v3 | 2020-09-15 | English | Compare |
v2 | 2020-09-14 | French | Compare |
v1 | 2020-09-14 | English | Compare |
Showing 1 to 13 of 13